Accessed 3/17/13
http://www.sciencefriday.com/segment/04/04/2008/genetic-testing.html
Apr. 04, 2008
Genetic Testing
Genetic tests pointing the way to personalized medical care are one of the most prominent results of genetic sequencing research. But what protections are in place to make sure that those tests are safe and dependable? Writing in a policy analysis in the journal Science this week, genetics policy experts argue that no mechanisms currently exist to ensure that genetic tests are supported by adequate evidence before they go to market, or that marketing claims on the up and up. “Marketing unproven tests to an unsuspecting public could undermine the very future of personalized medicine,” said Kathy Hudson, director of the Genetics and Public Policy Center at Johns Hopkins University and one of the authors of the report.
Some companies have even begun to offer at-home genetic tests that would provide the ability to scan a patient’s entire genome, looking for potential trouble spots. “Health professionals are now faced with the prospect of their patients coming to the office, a DNA profile in hand, asking for preventative management tailored to their specific disease risks,” wrote Ken Offit, Chief of the Clinical Genetics Service at Memorial Sloan-Kettering Cancer Center, in the March 19 special genomics issue of the Journal of the American Medical Association. In this segment, join Ira and guests for a look at the emerging field of personalized genetic testing. |
The Term Paper on Human Genome Project Genetic Test
Outline Thesis: Large corporations, such as insurance companies, and governments are looking to save money on future policyholders through the use of genetic testing. General information on the Human Genome Project Time of discussion leading up to implementation Who was involved Where does the funding come from Insurance Companies and discrimination Discrimination against unborn children Genetic ...
Produced by Karin Vergoth
http://www.geneticsandsociety.org/article.php?id=3995
http://www.iptv.org/exploremore/ge/uses/use2_medical.cfm
Medicine- DNA |
Some of the most promising and powerful applications of genetic engineering are in the field of medicine. Researchers are using it to diagnose and predict disease, and to develop therapies and drugs to treat devastating diseases like cancer, Alzheimer’s, diabetes, and cystic fibrosis. Explore more about ways genetic engineering techniques can be used for medical purposes. Recombinant DNA
Recombinant DNA is one of the core techniques of genetic engineering. It is the process of removing DNA from one organism and inserting it into the DNA of another organism, giving it new traits. Recombinant DNA can be used to make crops resistant to pests or disease, it can be used to make livestock leaner or larger. In medicine, the technique can be used to develop drugs, vaccines, and to reproduce important human hormones and proteins. By engineering human DNA into a host organism, that organism can be turned into a factory for important medical products. Insulin production is an excellent example of the recombinant DNA process. Host organisms can range from bacteria like E. coli, to plants, to animals.Genetically Engineered Pharmaceuticals * insulin for diabetics * factor VIII for males suffering from hemophilia A * factor IX for hemophilia B * human growth hormone (GH) * erythropoietin (EPO) for treating anemia * three types of interferons – fight viral infections * several interleukins * granulocyte-macrophage colony-stimulating factor (GM-CSF) for stimulating the bone marrow after a bone
The Essay on Genetic Engineering Organism Environment Plant
Many people have been discussing the scientific advancements recently made in genetic engineering. Genetic engineering has the ability to reconstruct an organism's DNA and chromosomes. Some believe that this new scientific ability will better our environment. However, I feel that genetic engineering has the potential to do more negative than positive.By altering an organism's genetic composition, ...
marrow transplant * tissue plasminogen activator (TPA) for dissolving blood clots * adenosine deaminase (ADA) for treating some forms of * severe combined immunodeficiency (SCID) * angiostatin and endostatin for trials as anti-cancer drugs * parathyroid hormone Explore More: Genetic Engineering
Copyright 2004, Iowa Public Television
The Explore More project is supported by funds from the
Roy J. Carver Charitable Trust
and the USDE Star Schools Program. |
|
|
